High levels of modified ceramides are a defining feature of murine and human cancer cachexia

BACKGROUND: Cancer cachexia (CCx) is a multifactorial energy‐wasting syndrome reducing the efficiency of anti‐cancer therapies, quality of life, and survival of cancer patients. In the past years, most studies focused on the identification of tumour and host‐derived proteins contributing to CCx. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Morigny, Pauline, Zuber, Julia, Haid, Mark, Kaltenecker, Doris, Riols, Fabien, Lima, Joanna D.C., Simoes, Estefania, Otoch, José Pinhata, Schmidt, Sören Fisker, Herzig, Stephan, Adamski, Jerzy, Seelaender, Marilia, Berriel Diaz, Mauricio, Rohm, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749558/
https://www.ncbi.nlm.nih.gov/pubmed/33090732
http://dx.doi.org/10.1002/jcsm.12626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749558/
https://www.ncbi.nlm.nih.gov/pubmed/33090732
http://dx.doi.org/10.1002/jcsm.12626

Ejemplares similares